Cefpodoxime

Author:Prof. Dr. med. Peter Altmeyer

Last updated on: 29.10.2020

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).

Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Oral cephalosporin.

Half-lifeThis section has been translated automatically.

2–3 h

Spectrum of actionThis section has been translated automatically.

Branhamella catarrhalis, Brucella spp., Corynebacterium diphtheriae, Citrobacter spp., Enterobacter spp., E. coli, Hafnia alvei, Haemophilus spp., Klebsiella spp, Morganella morganii, Neisseria spp., Pasteurella multocida, Proteus spp., Providentia spp., Salmonella spp., Shigella spp., Staphylococcus spp., Streptococcus spp., Yersinia enterocolica

Ineffective against enterococci, only weakly effective against staphylococcus.

IndicationThis section has been translated automatically.

Respiratory, urinary tract, skin and soft tissue infections.

Dosage and method of useThis section has been translated automatically.

2 times 100-200 mg/day p.o.
Children from 4th week: 5-12 mg/kg bw/day in 2 doses (juice).

PreparationsThis section has been translated automatically.

Orelox, Podomexef

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer